Advertisement
Screener

AbCellera Biologics Inc. (ABCL) Auditor

AbCellera Biologics Inc. Auditor

The independent registered public accounting firm that signed the audit report in each annual report on Form 10-K, newest first. PCAOB firm ID and the internal-control attestation are as tagged on the cover from fiscal 2021; earlier rows come from the signed report text.

  • 2026-02-24: Fiscal year end 2025-12-31; Auditor KPMG LLPChartered Professional Accountants; PCAOB firm ID 85; Location Vancouver, Canada.
  • 2025-02-27: Fiscal year end 2024-12-31; Auditor KPMG LLP; PCAOB firm ID 85; Location Vancouver, Canada.
  • 2024-02-20: Fiscal year end 2023-12-31; Auditor KPMG LLP; PCAOB firm ID 85; Location Vancouver, Canada.
  • 2023-02-21: Fiscal year end 2022-12-31; Auditor KPMG LLP; PCAOB firm ID 85; Location Vancouver, Canada.
FiledFiscal year endAuditorPCAOB firm IDLocationInternal-control attestation
2026-02-242025-12-31KPMG LLPChartered Professional Accountants85Vancouver, CanadaYes
2025-02-272024-12-31KPMG LLP85Vancouver, CanadaYes
2024-02-202023-12-31KPMG LLP85Vancouver, CanadaYes
2023-02-212022-12-31KPMG LLP85Vancouver, CanadaYes
2022-07-222021-12-31KPMG LLP85Vancouver, BC, CanadaYes
2022-02-252021-12-31KPMG LLP85Vancouver, CanadaYes
2021-03-302020-12-31KPMG LLPVancouver, Canada

Similar stocks

Stock NameCountryMarket CapPE Ratio
ACADIA PHARMACEUTICALS INC (ACAD)United States$3.823B11.45
Xenon Pharmaceuticals Inc. (XENE)$3.684B-14.27
Tango Therapeutics, Inc. (TNGX)United States$4.154B-42.53
Organon & Co. (OGN)United States$3.603B17.03
IDEAYA Biosciences, Inc. (IDYA)United States$3.540B-20.52
Indivior Pharmaceuticals, Inc. (INDV)$4.250B14.09
Viking Therapeutics, Inc. (VKTX)United States$4.287B-8.51
Amylyx Pharmaceuticals, Inc. (AMLX)United States$3.361B-13.15
Enliven Therapeutics, Inc. (ELVN)United States$3.307B-35.07
Arcutis Biotherapeutics, Inc. (ARQT)United States$3.303B115.47